Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 541-560 of 1,527 trials

Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma

NCT04559685

A Phase 0 single center, first in human, open-label study of ascending energy doses of sonodynamic therapy (SDT) utilizing the MRgFUS combined with intravenous ALA to assess safety and efficacy in up to 45 participants with recurrent HGG. Eligible participants who are scheduled for resection will be administered intravenous (IV) aminolevulinic acid HCl (ALA) approximately six to seven (6-7) hours prior to receiving sonodynamic therapy (SDT).

High Grade Glioma

Nader Sanai30 participantsStarted Mar 2021

Phoenix, Arizona, United States

COMPLETEDPHASE1/PHASE2< 1 mile

Myeloma-Developing Regimens Using Genomics (MyDRUG)

NCT03732703

The MyDRUG study is a type of Precision Medicine trial to treat patients with drugs targeted to affect specific genes that are mutated as part of the disease. Mutations in genes can lead to uncontrolled cell growth and cancer. Patients with a greater than 25% mutation to any of the following genes; CDKN2C, FGFR3, KRAS, NRAS, BRAF V600E, IDH2 or T(11;14) can be enrolled to one of the treatment arms. These arms have treatments specifically directed to the mutated genes. Patients that do not have a greater than 25% mutation to the genes listed can be enrolled to a non-actionable treatment arm. The genetic sequencing of the patient's tumor is required via enrollment to the MMRF002 study: Clinical-grade Molecular Profiling of Patients with Multiple Myeloma and Related Plasma Cell Malignancies. (NCT02884102).

Relapsed Refractory Multiple Myeloma

Multiple Myeloma Research Consortium103 participantsStarted Apr 2019

Phoenix, Arizona, United States • Duarte, California, United States • Atlanta, Georgia, United States +13 more locations

Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma

Myeloma-Developing Regimens Using Genomics (MyDRUG)

Rheumatoid Arthritis Trials in Other Cities

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

ViBone in Cervical and Lumbar Spine Fusion

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Advancing Understanding of Transportation Options

Persona Partial Knee Clinical Outcomes Study

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

FREEOAB Study for Overactive Bladder

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

Brain Injury Rehabilitation Improving the Transition Experience

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

Other Conditions in Phoenix